Waltham, MA, United States of America

Tieu-Binh Le

USPTO Granted Patents = 2 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tieu-Binh Le: Innovator in CSF-1R Inhibitors

Introduction

Tieu-Binh Le is a notable inventor based in Waltham, MA, who has made significant contributions to the field of biotechnology. With her innovative work, she has developed solutions that target critical biological processes, particularly through her research on Colony Stimulating Factor-1 Receptor (CSF-1R) inhibitors.

Latest Patents

Tieu-Binh Le holds a patent that focuses on Colony Stimulating Factor-1 Receptor inhibitors. This patent includes compounds formulated to serve as effective CSF-1R inhibitors, paving the way for advancements in therapeutic applications. Her groundbreaking work in this area underscores her commitment to innovation in health and medicine.

Career Highlights

As a pivotal member of Genzyme Corporation, Tieu-Binh Le has utilized her skills and expertise to contribute to various projects that drive the company's mission of advancing healthcare through innovative solutions. Her work not only benefits patients but also enhances the company’s portfolio in the biotechnology sector.

Collaborations

Throughout her career, Tieu-Binh Le has collaborated with esteemed colleagues such as John L Kane, Jr and Claude Barberis. These partnerships reflect her ability to work effectively within teams and contribute to complex projects that require diverse expertise.

Conclusion

Tieu-Binh Le's contributions to the field of biotechnology, particularly through her work on CSF-1R inhibitors, demonstrate her role as a leading inventor. Her achievements at Genzyme Corporation exemplify the impact that dedicated innovators can have on advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…